Chemicals and Drugs

Trastuzumab

A humanized monoclonal antibody against the ERBB-2 RECEPTOR (HER2). As an ANTINEOPLASTIC AGENT, it is used to treat BREAST CANCER where HER2 is overexpressed.

National Library of MedicineMedical Subject Headings2026

Structured Summary

Abstract

A humanized monoclonal antibody against the ERBB-2 RECEPTOR (HER2). As an ANTINEOPLASTIC AGENT, it is used to treat BREAST CANCER where HER2 is overexpressed.

MeSH Record

Classification

Related Concepts

Knowledge Graph

Loading graph…

Drag nodes to rearrange; hover to trace links; click a node to open its page.

Drug Class

Pharmacological Action

MeSH Record

See Also

MeSH Record

Synonyms

6 entry terms
  • Trastuzumab beta
  • beta, Trastuzumab
  • Herceptin
  • Trastuzumab-qyyp
  • Trazimera
  • Trastuzumab qyyp

MeSH Record

Aspects Covered

24 allowable subheadings

Indexed with the subheadings administration & dosage, adverse effects, analysis, biosynthesis, blood, cerebrospinal fluid, chemistry, classification, drug effects, economics, genetics, history, immunology, isolation & purification, metabolism, pharmacokinetics, pharmacology, physiology, poisoning, radiation effects, therapeutic use, toxicity, ultrastructure, urine.

MeSH Record

History Note

2016 (1998)

MeSH Hierarchy

Tree Numbers

AMA Style

References

  1. National Library of Medicine. Trastuzumab. Medical Subject Headings (MeSH). 2026. Unique ID D000068878. http://id.nlm.nih.gov/mesh/2026/D000068878
  2. Trastuzumab. In: Wikipedia. https://en.wikipedia.org/wiki/Trastuzumab
  3. Trastuzumab. In: Wikidata. https://www.wikidata.org/wiki/Q412616